HDAC6 and ovarian cancer: Various studies have analyzed the anti-cancer effect of the HDAC6 inhibitor, ACY-241, and its combination effect with standard platinum/taxane chemotherapy in different types of cancer, including ovarian cancer [18,20,32,33].